Parkinson's Disease: Eldepryl (selegiline) is a selective monoamine oxidase inhibitor type b mao-i. It increases the Dopamine available in the barin by inhibiting the monoamine oxidase (a naturally occurring enzyme in the brain involved in removing the neurotransmitters Dopamine and serotonin from the extracellular space).
Answered 6/25/2014
5.1k views
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question